SCHEMBL7187533

SCHEMBL7187533

COc1cccc(OC)c1C(=O)P(=O)(CC(C)CC(C)(C)C)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
TAAR1 Q96RJ0 1/20 0.39
HTT P42858 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
KCNK3 O14649 3/20 0.37
KCNK9 Q9NPC2 3/20 0.37
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7180610 0.92 FABP4 (0.36) CA12CA1CA2CA7CA9
SCHEMBL7179702 0.91 KMT2A (0.40) KMT2AMEN1SMN1; SMN2
SCHEMBL1467356 0.85 CA12 (0.38) CA12CA1CA2CA7CA9
SCHEMBL7187688 0.85 CA12 (0.46) CA12CA1CA2CA7CA9
SCHEMBL7181272 0.84 L3MBTL1 (0.36) L3MBTL1KCNK3KCNK9ALDH1A1GAA
SCHEMBL15237 0.84 CA12 (0.41) CA12CA1CA2CA7CA9
SCHEMBL5997076 0.84 CA12 (0.41) CA12CA1CA2CA7CA9
SCHEMBL7189073 0.83 ITGB1 (0.35) ALDH1A1GAAKMT2AMEN1TSHR
SCHEMBL5997250 0.83 CA12 (0.41) CA12CA1CA2CA7CA9
Phosphine SCHEMBL28321500 0.83 CA12 (0.41) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023190562-A1 CURABLE COMPOSITION CONTAINING WATER-INSOLUBLE MULTIFUNCTIONAL (METH)ACRYLAMIDE KJケミカルズ株式会社 2023-10-05 WO disclosed
CN-105392806-B Coloured composition, cured film, colored filter, the manufacture method of colored filter, solid photographic element and image display device 富士胶片株式会社 2018-04-17 CN disclosed
CN-107709407-A Polyimide precursor composition, photosensitive polymer combination, cured film, the manufacture method of cured film, the manufacture method of semiconductor devices and polyimide precursor composition 富士胶片株式会社 2018-02-16 CN disclosed
CN-104603209-B Dispersion composition, curable composition using same, transparent film, microlens, and solid-state imaging element 富士胶片株式会社 2017-11-24 CN disclosed
CN-104603210-B Dispersive composition, use the solidification compound of the dispersive composition, hyaline membrane, lenticule and solid-state imager 富士胶片株式会社 2017-10-17 CN disclosed
CN-103718106-B Coloring composition, coloring radiation-sensitive composition, color filter, and solid-state imaging device 富士胶片株式会社 2017-10-17 CN disclosed
CN-105122427-B The manufacture method of semiconductor device manufacture temporary adhesion layered product and semiconductor device 富士胶片株式会社 2017-09-19 CN disclosed
CN-105593317-B pigment dispersion composition, inkjet recording method, and method for producing compound 富士胶片株式会社 2017-09-19 CN disclosed
CN-105103267-B Laminate for temporary bonding for manufacturing semiconductor device, and method for manufacturing semiconductor device 富士胶片株式会社 2017-09-19 CN disclosed
CN-107075149-A Method for producing water-absorbent polymer sheet 迪睿合株式会社 2017-08-18 CN disclosed
CN-103842449-A Inkjet ink composition and inkjet recording method FUJI PHOTO FILM CO LTD 2014-06-04 CN disclosed
CN-103827228-A Coloring composition, colored cured film, color filter, method for producing the same, and solid-state imaging device FUJI PHOTO FILM CO LTD 2014-05-28 CN disclosed
CN-103718106-A Coloring composition, coloring radiation-sensitive composition, color filter, and solid-state imaging device FUJI PHOTO FILM CO LTD 2014-04-09 CN disclosed
CN-102127339-A Inkjet ink composition and inkjet recording method FUJIFILM CORP 2011-07-20 CN disclosed
CN-1200943-C Organometallic acyl-aryl phosphine CIBA SC HOLDING AG (CH) 2005-05-11 CN disclosed
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed
CN-1308081-A Organometallic acyl-aryl phosphine CIBA SC HOLDING AG (CH) 2001-08-15 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 CA12 1552/4885CA1 2219/4885CA2 2297/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 CA12 1320/4885CA1 2302/4885CA2 2346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.